AbbVie
ABBV
#26
Rank
C$507.45 B
Marketcap
$286.86
Share price
-3.74%
Change (1 day)
18.28%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$187.77 Billion

According to AbbVie's latest financial reports the company's total liabilities are C$187.77 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$189.12 B14.7%
2023-12-31C$164.88 B-0.01%
2022-12-31C$164.89 B-1.3%
2021-12-31C$167.07 B-4.68%
2020-12-31C$175.28 B37.95%
2019-12-31C$127.06 B37.58%
2018-12-31C$92.35 B11.83%
2017-12-31C$82.58 B-0.01%
2016-12-31C$82.59 B21.26%
2015-12-31C$68.11 B127.77%
2014-12-31C$29.90 B13.72%
2013-12-31C$26.29 B11.85%
2012-12-31C$23.51 B204.59%
2011-12-31C$7.71 B42.18%
2010-12-31C$5.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$177.95 B-5.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$108.58 B-42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
C$91.81 B-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$122.47 B-34.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$56.63 B-69.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$16.14 B-91.40%๐Ÿ‡บ๐Ÿ‡ธ USA
C$82.91 B-55.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$89.99 B-52.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$1.60 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA